This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Supratek Pharma Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Michael Parniak: Innovator in Antisense Oligonucleotide Constructs
Introduction
Michael Parniak is a notable inventor based in Verdun, CA. He has made significant contributions to the field of modified oligonucleotide therapeutic agents. His work focuses on the selective prevention of gene transcription and expression through innovative strategies.
Latest Patents
Michael Parniak holds a patent titled "Antisense Oligonucleotide Constructs Based On .beta.-Arabinofuranose And Its Analogues." This invention relates to the development of therapeutic agents that utilize antisense strategies to inhibit protein biosynthesis. The oligonucleotides he has constructed are designed to hybridize with complementary RNA, including cellular messenger RNA and viral RNA.
Career Highlights
Throughout his career, Michael has worked with various companies, including Gadip Borkow and Massad Jose Damha. His expertise in the field of oligonucleotide therapeutics has positioned him as a key figure in advancing gene expression technologies.
Collaborations
Michael has collaborated with notable individuals such as Gadip Borkow and Massad Jose Damha, contributing to the development of innovative therapeutic solutions.
Conclusion
Michael Parniak's work in antisense oligonucleotide constructs showcases his dedication to advancing medical science through innovative inventions. His contributions are significant in the realm of gene therapy and therapeutic agents.